GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (FRA:7ZA) » Definitions » Common Stock

Ascelia Pharma AB (FRA:7ZA) Common Stock : €8.45 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Ascelia Pharma AB Common Stock?

Ascelia Pharma AB's quarterly common stock increased from Jun. 2024 (€3.09 Mil) to Sep. 2024 (€8.56 Mil) but then declined from Sep. 2024 (€8.56 Mil) to Dec. 2024 (€8.45 Mil).

Ascelia Pharma AB's annual common stock declined from Dec. 2022 (€3.17 Mil) to Dec. 2023 (€3.12 Mil) but then increased from Dec. 2023 (€3.12 Mil) to Dec. 2024 (€8.45 Mil).


Ascelia Pharma AB Common Stock Historical Data

The historical data trend for Ascelia Pharma AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Common Stock Chart

Ascelia Pharma AB Annual Data
Trend Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial 2.82 3.37 3.17 3.12 8.45

Ascelia Pharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.12 3.08 3.09 8.56 8.45

Ascelia Pharma AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Ascelia Pharma AB Business Description

Traded in Other Exchanges
Address
Hyllie Boulevard 34, Malmo, SWE, SE-215 32
Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo Sweden focused on orphan oncology It develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway The company has two drug candidates Orviglance and Oncoral in clinical development.

Ascelia Pharma AB Headlines

No Headlines